Sign in
4

Changes in Ownership

Krystal Biotech, Inc. Filed Acc 0001209059-26-000003

Director sold 18,950 shares at an average $261.41 ($4,953,694)

  • Director acquired 18,950 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROSSI DINO A · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-19 Exercise or conversion : show line 1 in the form +18,950 $8.79 $166,571 97,641 D
2026-02-19 Sale : show line 2 in the form −8,116 $260.49 $2,114,103 89,525 D
2026-02-19 Sale : show line 3 in the form −10,834 $262.10 $2,839,591 78,691 D
Open-market sales · 18,950 sh · avg $261.41 · $4,953,694

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-19 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −18,950 0 D
Loading xslF345X05/wk-form4_1771892075.xml…